Allianz Asset Management
CLBT icon

Allianz Asset Management’s Cellebrite CLBT Stock Holding History

Allianz Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.27M Buy
+382,376
New +$5.76M 0.01% 1139
2025
Q3 		– Sell
-18,521
Closed -$296K – 2012
2025
Q2 		$296K Sell
18,521
-5,984
-24% -$107K ﹤0.01% 1907
2025
Q1 		$476K Buy
+24,505
New +$516K ﹤0.01% 1892

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management's CLBT Position: Q1 2026 in Review

Allianz Asset Management opened a new position in Cellebrite (CLBT) in Q1 2026: 382,376 shares worth $5.27M. The stake represents 0.01% of the portfolio and ranks #1139 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in CLBT as recently as Q2 2025.

Allianz Asset Management first reported a position in CLBT in Q1 2025 and has held it in 3 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Allianz Asset Management held 382,376 shares of Cellebrite worth $5.27M as of Q1 2026.
  • Cellebrite was a new Allianz Asset Management position in Q1 2026.
  • Cellebrite made up 0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1139 holding.
  • Allianz Asset Management first reported a position in Cellebrite in Q1 2025 and has held it in 3 quarters since.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.